2024 Q2 Form 10-Q Financial Statement

#000162828024020695 Filed on May 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $99.14M $94.50M
YoY Change 24.94% 7.29%
Cost Of Revenue $5.072M $6.740M
YoY Change -10.71% -819053.83%
Gross Profit $94.07M $87.76M
YoY Change 27.69% -0.36%
Gross Profit Margin 94.88% 92.87%
Selling, General & Admin $27.20M $26.00M
YoY Change 18.96% 5.21%
% of Gross Profit 28.91% 29.63%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $24.70M $23.79M
YoY Change 18.79% 11.85%
% of Gross Profit 26.26% 27.11%
Operating Expenses $52.25M $50.15M
YoY Change 18.72% 8.19%
Operating Profit $41.82M $37.62M
YoY Change 41.0% 5.51%
Interest Expense -$12.63M $11.50M
YoY Change 75.26% 10.67%
% of Operating Profit -30.2% 30.57%
Other Income/Expense, Net -$12.58M -$30.37M
YoY Change -10886.77% 3253.03%
Pretax Income $29.24M $7.244M
YoY Change 30.33% -79.15%
Income Tax $6.820M $1.729M
% Of Pretax Income 23.33% 23.87%
Net Earnings $22.42M $5.515M
YoY Change -22.13% -83.14%
Net Earnings / Revenue 22.61% 5.84%
Basic Earnings Per Share $0.11 $0.03
Diluted Earnings Per Share $0.11 $0.03
COMMON SHARES
Basic Shares Outstanding 197.9M shares 197.9M shares
Diluted Shares Outstanding 200.4M shares 199.3M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.179M $1.376M
YoY Change -32.64% -20.26%
Cash & Equivalents $1.179M $1.376M
Short-Term Investments
Other Short-Term Assets $5.992M $5.076M
YoY Change -47.29% -35.97%
Inventory $5.776M $5.966M
Prepaid Expenses $2.622M $1.371M
Receivables $41.58M $44.39M
Other Receivables $1.698M $1.857M
Total Short-Term Assets $56.22M $58.67M
YoY Change 2.03% 0.35%
LONG-TERM ASSETS
Property, Plant & Equipment $1.318B $1.307B
YoY Change 9.72% 9.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.67M $16.90M
YoY Change -47.47% -27.63%
Total Long-Term Assets $1.334B $1.326B
YoY Change 8.69% 8.43%
TOTAL ASSETS
Total Short-Term Assets $56.22M $58.67M
Total Long-Term Assets $1.334B $1.326B
Total Assets $1.390B $1.385B
YoY Change 8.4% 8.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $90.01M $99.15M
YoY Change -0.01% -0.88%
Accrued Expenses $622.7K $612.4K
YoY Change 57.88% 51.27%
Deferred Revenue
YoY Change
Short-Term Debt $1.356M $0.00
YoY Change -4.03%
Long-Term Debt Due $948.3K $1.004M
YoY Change 24.59% 34.66%
Total Short-Term Liabilities $111.4M $118.4M
YoY Change 10.36% 7.27%
LONG-TERM LIABILITIES
Long-Term Debt $407.7M $422.9M
YoY Change 2.49% -0.02%
Other Long-Term Liabilities $36.40M $40.22M
YoY Change -9.87% 4.74%
Total Long-Term Liabilities $444.1M $463.1M
YoY Change 1.35% 0.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $111.4M $118.4M
Total Long-Term Liabilities $444.1M $463.1M
Total Liabilities $572.3M $591.7M
YoY Change 5.37% 1.63%
SHAREHOLDERS EQUITY
Retained Earnings $18.49M -$3.933M
YoY Change -135.01% -95.18%
Common Stock $198.2K $197.9K
YoY Change 1.44% 9.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $817.4M $793.0M
YoY Change
Total Liabilities & Shareholders Equity $1.390B $1.385B
YoY Change 8.4% 8.06%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $22.42M $5.515M
YoY Change -22.13% -83.14%
Depreciation, Depletion And Amortization $24.70M $23.79M
YoY Change 18.79% 11.85%
Cash From Operating Activities $50.62M $45.19M
YoY Change 16.72% 3.45%
INVESTING ACTIVITIES
Capital Expenditures $36.87M $39.51M
YoY Change 1.18% 6.73%
Acquisitions
YoY Change
Other Investing Activities $10.61K $0.00
YoY Change -99.87% -100.0%
Cash From Investing Activities -$36.86M -$39.51M
YoY Change 31.1% -28.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -13.95M -$4.604M
YoY Change -8.35% -146.97%
NET CHANGE
Cash From Operating Activities 50.62M $45.19M
Cash From Investing Activities -36.86M -$39.51M
Cash From Financing Activities -13.95M -$4.604M
Net Change In Cash -197.3K $1.080M
YoY Change -912.44% -154.34%
FREE CASH FLOW
Cash From Operating Activities $50.62M $45.19M
Capital Expenditures $36.87M $39.51M
Free Cash Flow $13.75M $5.684M
YoY Change 98.53% -14.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#DerivativeAssetsCurrent http://fasb.org/us-gaap/2023#DerivativeAssetsNoncurrent
CY2023Q4 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#DerivativeLiabilitiesCurrent http://fasb.org/us-gaap/2023#DerivativeLiabilitiesNoncurrent
CY2024Q1 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#DerivativeAssetsCurrent http://fasb.org/us-gaap/2023#DerivativeAssetsNoncurrent
CY2024Q1 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#DerivativeLiabilitiesCurrent http://fasb.org/us-gaap/2023#DerivativeLiabilitiesNoncurrent
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
196837001 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
196837001 shares
CY2024Q1 rei Direct Costs Of Lease Operating Expenses
DirectCostsOfLeaseOperatingExpenses
18360434 usd
CY2023Q1 rei Direct Costs Of Lease Operating Expenses
DirectCostsOfLeaseOperatingExpenses
17472691 usd
CY2024Q1 rei Cost Of Goods And Services Sold Including Payout Adjustments
CostOfGoodsAndServicesSoldIncludingPayoutAdjustments
166054 usd
CY2023Q1 rei Cost Of Goods And Services Sold Including Payout Adjustments
CostOfGoodsAndServicesSoldIncludingPayoutAdjustments
-823 usd
CY2024Q1 rei Ad Valorem Taxes
AdValoremTaxes
2145631 usd
CY2023Q1 rei Ad Valorem Taxes
AdValoremTaxes
1670613 usd
CY2024Q1 us-gaap Production Tax Expense
ProductionTaxExpense
4428303 usd
CY2023Q1 us-gaap Production Tax Expense
ProductionTaxExpense
4408140 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23792450 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21271671 usd
CY2024Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
350834 usd
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
365847 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
175091 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
113138 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7469222 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7130139 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
56888019 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
52431416 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
37615117 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
35651496 usd
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
78544 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
11498944 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
10390279 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-19014495 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
9474905 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
38355 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0 usd
CY2024Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
25686 usd
CY2023Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
9600 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30370854 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-905774 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7244263 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
34745722 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1728886 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2029943 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
5515377 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
32715779 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
786582900 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q1 rei Share Based Payment Arrangement Value Withheld For Tax Withholding Obligation With Restricted Stock Vested
ShareBasedPaymentArrangementValueWithheldForTaxWithholdingObligationWithRestrictedStockVested
0 usd
CY2024Q1 rei Adjustment To Additional Paid In Capital Payment To Cover Tax Withholdings Income Tax Effect
AdjustmentToAdditionalPaidInCapitalPaymentToCoverTaxWithholdingsIncomeTaxEffect
-814985 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1723832 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
5515377 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
793007124 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
661103391 usd
CY2023Q1 rei Stock Issued During Period Value Common Warrants Exercised
StockIssuedDuringPeriodValueCommonWarrantsExercised
3613941 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q1 rei Share Based Payment Arrangement Value Withheld For Tax Withholding Obligation With Restricted Stock Vested
ShareBasedPaymentArrangementValueWithheldForTaxWithholdingObligationWithRestrictedStockVested
0 usd
CY2023Q1 rei Adjustment To Additional Paid In Capital Payment To Cover Tax Withholdings Income Tax Effect
AdjustmentToAdditionalPaidInCapitalPaymentToCoverTaxWithholdingsIncomeTaxEffect
-134381 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1943696 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
32715779 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
699242426 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
5515377 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
32715779 usd
CY2024Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
23792450 usd
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
21271671 usd
CY2024Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
350834 usd
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
365847 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1221607 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1220384 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1723832 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1943696 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
163840 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2894 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-1585445 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-1972653 usd
CY2024Q1 rei Excess Tax Benefit Expense Related To Share Based Compensation
ExcessTaxBenefitExpenseRelatedToShareBasedCompensation
-40808 usd
CY2023Q1 rei Excess Tax Benefit Expense Related To Share Based Compensation
ExcessTaxBenefitExpenseRelatedToShareBasedCompensation
0 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-19014495 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
9474905 usd
CY2024Q1 rei Cash Received Paid For Derivative Settlements Net
CashReceivedPaidForDerivativeSettlementsNet
-1461515 usd
CY2023Q1 rei Cash Received Paid For Derivative Settlements Net
CashReceivedPaidForDerivativeSettlementsNet
-658525 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5240487 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3428287 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-171416 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-442598 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-503704 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-529934 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1601276 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9589898 usd
CY2024Q1 us-gaap Increase Decrease In Asset Retirement Obligations
IncreaseDecreaseInAssetRetirementObligations
-591361 usd
CY2023Q1 us-gaap Increase Decrease In Asset Retirement Obligations
IncreaseDecreaseInAssetRetirementObligations
-490319 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
45189169 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
43680096 usd
CY2024Q1 us-gaap Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
475858 usd
CY2023Q1 us-gaap Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
59099 usd
CY2024Q1 us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
38904808 usd
CY2023Q1 us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
36939307 usd
CY2024Q1 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
124937 usd
CY2023Q1 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
14570 usd
CY2024Q1 us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
0 usd
CY2023Q1 us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
54558 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39505603 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-55469588 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
51500000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
56000000 usd
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
54500000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
49000000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3613941 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
814985 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
134381 usd
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
533734 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
499880 usd
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
255156 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
177014 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4603875 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9802666 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1079691 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1986826 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
296384 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3712526 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1376075 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1725700 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
9926520 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
9246281 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 us-gaap Asset Retirement Obligation Period Increase Decrease
AssetRetirementObligationPeriodIncreaseDecrease
168848 usd
CY2023Q1 us-gaap Asset Retirement Obligation Period Increase Decrease
AssetRetirementObligationPeriodIncreaseDecrease
95062 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
254855 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
83811 usd
CY2024Q1 rei Capital Expenditures Incurred But Not Yet Paid1
CapitalExpendituresIncurredButNotYetPaid1
-3120789 usd
CY2023Q1 rei Capital Expenditures Incurred But Not Yet Paid1
CapitalExpendituresIncurredButNotYetPaid1
1981649 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
163840 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2894 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The Company’s unaudited condensed financial statements are based on a number of significant estimates, including estimates of oil and natural gas reserve quantities, which are the basis for the calculation of depletion and impairment of oil and gas properties. Reserve estimates, by their nature, are inherently imprecise. Actual results could differ from those estimates. Changes in the future </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimated oil and natural gas reserves or the estimated future cash flows attributable to the reserves that are utilized for impairment analysis could have a significant impact on the Company’s future results of operations.</span></div>
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and receivables.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had cash in excess of federally insured limits of $1,126,075 and $46,384 as of March 31, 2024 and December 31, 2023, respectively. The Company places its cash with a high credit quality financial institution. The Company has not experienced any losses in such accounts and believes it is not exposed to significant credit risk in this area.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts receivable - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s accounts receivable is from purchasers of oil and natural gas. Oil and natural gas sales are generally unsecured. Accounts receivable from purchasers outstanding longer than the contractual </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payment terms are considered past due. The Company has not had any significant credit losses in the past and believes its accounts receivable are fully collectable. During the three months ended March 31, 2024, sales to three purchasers represented 61%, 13% and 12%, respectively, of total oil, natural gas, and natural gas liquids sales. As of March 31, 2024, receivables outstanding from these three purchasers represented 59%, 12% and 11%, respectively, of accounts receivable. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Production imbalances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">- </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for natural gas production imbalances using the sales method, which recognizes revenue on all natural gas sold even though the natural gas volumes sold may be more or less than the Company's ownership entitles it to sell. Liabilities are recorded for imbalances greater than the Company’s proportionate share of remaining estimated natural gas reserves.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded no imbalances as of March 31, 2024 or December 31, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Joint interest billing receivables, net - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has joint interest billing receivables. Joint interest billing receivables are collateralized by the pro rata revenue attributable to the joint interest holders and further by the interest itself. Receivables from joint interest owners outstanding longer than the contractual payment terms are considered past due. The following table indicates the Company's provisions for bad debt expense associated with its joint interest billing receivables during the three months ended March 31, 2024 and March 31, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,840 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,894 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>
CY2024Q1 us-gaap Fair Value Concentration Of Risk Cash And Cash Equivalents
FairValueConcentrationOfRiskCashAndCashEquivalents
1126075 usd
CY2023Q4 us-gaap Fair Value Concentration Of Risk Cash And Cash Equivalents
FairValueConcentrationOfRiskCashAndCashEquivalents
46384 usd
CY2024Q1 rei Oil And Gas Joint Interest Billing Receivables Before Allowance For Credit Loss
OilAndGasJointInterestBillingReceivablesBeforeAllowanceForCreditLoss
2042925 usd
CY2023Q4 rei Oil And Gas Joint Interest Billing Receivables Before Allowance For Credit Loss
OilAndGasJointInterestBillingReceivablesBeforeAllowanceForCreditLoss
2480843 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
185684 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
58569 usd
CY2024Q1 us-gaap Oil And Gas Joint Interest Billing Receivables Current
OilAndGasJointInterestBillingReceivablesCurrent
1857241 usd
CY2023Q4 us-gaap Oil And Gas Joint Interest Billing Receivables Current
OilAndGasJointInterestBillingReceivablesCurrent
2422274 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
127115 usd
CY2024Q1 us-gaap Depletion Of Oil And Gas Properties
DepletionOfOilAndGasProperties
23429612 usd
CY2023Q1 us-gaap Depletion Of Oil And Gas Properties
DepletionOfOilAndGasProperties
20980542 usd
CY2024Q1 rei Depletion Rate Per Barrel Of Oil Equivalents
DepletionRatePerBarrelOfOilEquivalents
13.53 usd
CY2023Q1 rei Depletion Rate Per Barrel Of Oil Equivalents
DepletionRatePerBarrelOfOilEquivalents
12.74 usd
CY2024Q1 us-gaap Depreciation
Depreciation
101937 usd
CY2023Q1 us-gaap Depreciation
Depreciation
105101 usd
CY2024Q1 rei Notes Payable Current For Obtaining External Insurance
NotesPayableCurrentForObtainingExternalInsurance
0 usd
CY2024Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1551759 usd
CY2023Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1529249 usd
CY2024Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
102633 usd
CY2023Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
57291 usd
CY2024Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
74494 usd
CY2023Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
443403 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1728886 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2029943 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.239
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1723832 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1943696 usd
CY2024Q1 rei Oil Revenue
OilRevenue
92294585 usd
CY2023Q1 rei Oil Revenue
OilRevenue
83586327 usd
CY2024Q1 rei Natural Gas Revenue
NaturalGasRevenue
-818235 usd
CY2023Q1 rei Natural Gas Revenue
NaturalGasRevenue
1064563 usd
CY2024Q1 rei Natural Gas Liquids Revenue
NaturalGasLiquidsRevenue
3026786 usd
CY2023Q1 rei Natural Gas Liquids Revenue
NaturalGasLiquidsRevenue
3432022 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
94503136 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
88082912 usd
CY2024Q1 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P36M
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
532397 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
727460 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
636649 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
460497 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
250606 usd
CY2024Q1 rei Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
149628 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
845252 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
808632 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
335634 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
15855 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0 usd
CY2024Q1 rei Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
0 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0450
CY2024Q1 rei Operating Lease Imputed Interest Expense
OperatingLeaseImputedInterestExpense
248687 usd
CY2024Q1 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P4Y1M6D
CY2024Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0688
CY2024Q1 rei Finance Lease Imputed Interest Expense
FinanceLeaseImputedInterestExpense
143090 usd
CY2024Q1 us-gaap Lessee Finance Lease Remaining Lease Term
LesseeFinanceLeaseRemainingLeaseTerm
P1Y11M26D
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
612373 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
568176 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1896177 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2054041 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2508550 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2622217 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2757237 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2900050 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
248687 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
277833 usd
CY2024Q1 rei Lessee Operating Lease Liability Payments Due Net Of Imputed Interest
LesseeOperatingLeaseLiabilityPaymentsDueNetOfImputedInterest
2508550 usd
CY2023Q4 rei Lessee Operating Lease Liability Payments Due Net Of Imputed Interest
LesseeOperatingLeaseLiabilityPaymentsDueNetOfImputedInterest
2622217 usd
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1003909 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
956254 usd
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
858374 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
906330 usd
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
1862283 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
1862584 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
2005373 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
2006453 usd
CY2024Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
143090 usd
CY2023Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
143869 usd
CY2024Q1 rei Finance Lease Liability To Be Paid Net Of Imputed Interest
FinanceLeaseLiabilityToBePaidNetOfImputedInterest
1862283 usd
CY2023Q4 rei Finance Lease Liability To Be Paid Net Of Imputed Interest
FinanceLeaseLiabilityToBePaidNetOfImputedInterest
1862584 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
175091 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
113138 usd
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
981291 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1213799 usd
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
260901 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
186028 usd
CY2024Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
31317 usd
CY2023Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
25431 usd
CY2024Q1 us-gaap Derivative Instruments And Hedges
DerivativeInstrumentsAndHedges
4493001 usd
CY2023Q4 us-gaap Derivative Instruments And Hedges
DerivativeInstrumentsAndHedges
7768697 usd
CY2024Q1 rei Derivative Instruments And Hedges Assets Discounted Deferred Premiums Current
DerivativeInstrumentsAndHedgesAssetsDiscountedDeferredPremiumsCurrent
788555 usd
CY2023Q4 rei Derivative Instruments And Hedges Assets Discounted Deferred Premiums Current
DerivativeInstrumentsAndHedgesAssetsDiscountedDeferredPremiumsCurrent
1553323 usd
CY2024Q1 rei Derivative Instruments And Hedges Assets Net Of Discounted Deferred Premiums Current
DerivativeInstrumentsAndHedgesAssetsNetOfDiscountedDeferredPremiumsCurrent
3704446 usd
CY2023Q4 rei Derivative Instruments And Hedges Assets Net Of Discounted Deferred Premiums Current
DerivativeInstrumentsAndHedgesAssetsNetOfDiscountedDeferredPremiumsCurrent
6215374 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
5515377 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
32715779 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
197389782 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
177984323 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
199305150 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
190138969 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2022Q3 rei Company Required To Maintaining Rolling Basis
CompanyRequiredToMaintainingRollingBasis
P24M
CY2022Q3 rei Hedge Testing Percentage
HedgeTestingPercentage
0
CY2022Q3 rei Minimum Percentage Of Projected Production To Be Hedged
MinimumPercentageOfProjectedProductionToBeHedged
0.50
CY2022Q3 rei Company Required To Maintaining Rolling Basis
CompanyRequiredToMaintainingRollingBasis
P24M
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
422000000 usd
CY2024Q1 us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.005
CY2024Q1 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
178000000 usd
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
422000000 usd
CY2022Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
600000000 usd
CY2024Q1 us-gaap Derivative Instruments And Hedges Noncurrent
DerivativeInstrumentsAndHedgesNoncurrent
5092176 usd
CY2023Q4 us-gaap Derivative Instruments And Hedges Noncurrent
DerivativeInstrumentsAndHedgesNoncurrent
11634714 usd
CY2024Q1 rei Derivative Instruments And Hedges Assets Discounted Deferred Premiums Noncurrent
DerivativeInstrumentsAndHedgesAssetsDiscountedDeferredPremiumsNoncurrent
0 usd
CY2023Q4 rei Derivative Instruments And Hedges Assets Discounted Deferred Premiums Noncurrent
DerivativeInstrumentsAndHedgesAssetsDiscountedDeferredPremiumsNoncurrent
0 usd
CY2024Q1 rei Derivative Instruments And Hedges Assets Net Of Discounted Deferred Premiums Noncurrent
DerivativeInstrumentsAndHedgesAssetsNetOfDiscountedDeferredPremiumsNoncurrent
5092176 usd
CY2023Q4 rei Derivative Instruments And Hedges Assets Net Of Discounted Deferred Premiums Noncurrent
DerivativeInstrumentsAndHedgesAssetsNetOfDiscountedDeferredPremiumsNoncurrent
11634714 usd
CY2024Q1 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
17517656 usd
CY2023Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
7520336 usd
CY2024Q1 us-gaap Derivative Instruments And Hedges Liabilities Noncurrent
DerivativeInstrumentsAndHedgesLiabilitiesNoncurrent
10012561 usd
CY2023Q4 us-gaap Derivative Instruments And Hedges Liabilities Noncurrent
DerivativeInstrumentsAndHedgesLiabilitiesNoncurrent
11510368 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-19014495 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
9474905 usd
CY2024Q1 rei Derivative Cost Of Hedge Net Of Cash Paid And Received
DerivativeCostOfHedgeNetOfCashPaidAndReceived
-1461515 usd
CY2023Q1 rei Derivative Cost Of Hedge Net Of Cash Paid And Received
DerivativeCostOfHedgeNetOfCashPaidAndReceived
-658525 usd
CY2014Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
1000000000 usd
CY2022Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
600000000 usd
CY2024Q1 rei Debt Instrument Covenant Pro Forma Leverage Ratio Maximum Threshold
DebtInstrumentCovenantProFormaLeverageRatioMaximumThreshold
2.00
CY2024Q1 rei Debt Instrument Borrowing Base Utilization Maximum Threshold Percentage
DebtInstrumentBorrowingBaseUtilizationMaximumThresholdPercentage
0.80
CY2022Q3 rei Company Required To Maintaining Rolling Basis
CompanyRequiredToMaintainingRollingBasis
P24M
CY2022Q3 rei Minimum Percentage Of Projected Production To Be Hedged
MinimumPercentageOfProjectedProductionToBeHedged
0.50
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
28248084 usd
CY2024Q1 rei Asset Retirement Obligation Liabilities Acquired
AssetRetirementObligationLiabilitiesAcquired
0 usd
CY2024Q1 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
168848 usd
CY2024Q1 rei Asset Retirement Obligation Liabilities Properties Sold
AssetRetirementObligationLiabilitiesPropertiesSold
0 usd
CY2024Q1 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
422564 usd
CY2024Q1 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
0 usd
CY2024Q1 us-gaap Accretion Expense
AccretionExpense
350834 usd
CY2024Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
28345202 usd
CY2024Q1 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
36318 usd
CY2023Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
165642 usd
CY2024Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
28308884 usd
CY2023Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
28082442 usd
CY2024Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
28345202 usd
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
28248084 usd
CY2022Q1 rei Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised
0.80
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
3613941 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
8997543 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
0 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
0 usd
CY2023Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
8997543 usd
CY2022Q4 rei Stock Issued During Period Value Common Warrants Exercised
StockIssuedDuringPeriodValueCommonWarrantsExercised
8687655 usd
CY2024Q1 rei Payment Of Stock Issuance Costs Advisory Fees
PaymentOfStockIssuanceCostsAdvisoryFees
309888 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1723832 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1943696 usd
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
5.50
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
25000 usd
CY2024Q1 rei Number Of Guarantors Issuing Instruments On Behalf Of The Company
NumberOfGuarantorsIssuingInstrumentsOnBehalfOfTheCompany
2 insurancecompany
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-24-020695-index-headers.html Edgar Link pending
0001628280-24-020695-index.html Edgar Link pending
0001628280-24-020695.txt Edgar Link pending
0001628280-24-020695-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q12024ex311-rule13ax14acer.htm Edgar Link pending
q12024ex312-rule13ax14acer.htm Edgar Link pending
q12024ex321-section1350cer.htm Edgar Link pending
q12024ex322-section1350cer.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
rei-20240331.htm Edgar Link pending
rei-20240331.xsd Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
rei-20240331_def.xml Edgar Link unprocessable
rei-20240331_lab.xml Edgar Link unprocessable
rei-20240331_pre.xml Edgar Link unprocessable
rei-20240331_htm.xml Edgar Link completed
rei-20240331_cal.xml Edgar Link unprocessable